Real-time enrollment status for this neuromyelitis optica spectrum disorder clinical trial
Current Status
Recruiting
Checked: October 15, 2026 at 7:04 AM UTC
| NCT Number | NCT05199688 |
| Recruiting Status | Recruiting |
| Condition | Neuromyelitis Optica Spectrum Disorder |
| Phase | PHASE3 |
| Target Enrollment | 8 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Hoffmann-La Roche |
| Last Updated on CT.gov | October 1, 2026 (2 weeks ago) |
As of October 15, 2026: Clinical trial NCT05199688 is currently recruiting participants. This phase3 study for neuromyelitis optica spectrum disorder is actively seeking new participants at 1 location across the United States. The study is sponsored by Hoffmann-La Roche. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05199688 is actively recruiting participants as of October 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05199688 was last updated 2 weeks ago (October 1, 2026). HelloStudys verifies this status automatically.